glp-1/gip agonist GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal gip/glp-1 agonists TrimRX

For example, extremely high doses of magnesium are more likely to cause diarrhea, while large doses of fiber without adequate fluid can actually worsen constipation and make stool harder to pass

Novo Nordisk A/S: Wegovy Pill Approved in the US as First Oral GLP-1 for Weight Management

Unlike GLP-1 medications that target one or two pathways, surgery resets multiple signaling systems, creating a more comprehensive and permanent effect on weight regulation, says Dr

Some people experience nausea or other gastrointestinal effects when using GLP-1 agonists

This allows for proper risk assessment and an appropriate care plan before starting therapy

Neurobiol Aging (2018) 64:3343